We recommended AstraZeneca India -Improving Fundamentals + Delisting support at Rs. 1194 in Feb2016. In two year, the stock has underperformed and is trading at a current market price of Rs. 1150.

The delisting process has been stuck indefinitely and the business improvement is taking longer than anticipated. In this light, we suggest to Exit from AstraZeneca Pharma India.

Share On